Pandemic aspect of dexamethasone: Molecular mechanisms and clinical application
- PMID: 33433137
- DOI: 10.1097/JCMA.0000000000000485
Pandemic aspect of dexamethasone: Molecular mechanisms and clinical application
Abstract
The rapid spread of coronavirus disease (COVID-19) in many countries has caused inconvenience in conducting daily life activities, and even deaths. Dexamethasone is a corticosteroid applied in clinical medicine since 1957, especially in immune therapy fields. Herein, we present the characteristics of Dexamethasone, from molecular mechanisms such as genomic and nongenomic pathways by cellular signal regulations, to clinical applications in various phases of the disease. During COVID-19 pandemic, Dexamethasone given to patients who required oxygen or ventilation therapy showed improved life efficacy.
Copyright © 2020, the Chinese Medical Association.
Conflict of interest statement
Conflicts of interest: The authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article.
References
-
- Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: an overview. J Chin Med Assoc 2020; 83:217–20.
-
- WHO Corticosteroids for COVID-19. 2 Sep/COVID-19: clinic care. Available at https://www.who.int/news-room/feature-stories/detail/who-updates-clinica... . Accessed September 2, 2020.
-
- Moss GP. The Working Party of the IUPAC-IUB Joint Commission on Biochemical Nomenclature of steroids. Pure Appl Chem 1986; 61:1783–822.
-
- Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids–new mechanisms for old drugs. N Engl J Med 2005; 353:1711–23.
-
- Fahy E, Subramaniam S, Brown HA, Glass CK, Merrill AH Jr, Murphy RC, et al. A comprehensive classification system for lipids. J Lipid Res 2005; 46:839–61.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
